Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 19 at 2:00 PM EDT

Register Free →

COLUMBUS COUNTY SCHOOLS

UEI: RC9LFKC1MFU3CAGE: 4CCP1

COLUMBUS COUNTY SCHOOLS is a federal contractor, registered under UEI RC9LFKC1MFU3 and CAGE code 4CCP1. It has been awarded $21,586,668 across 40 federal contracts. Primary work spans Unknown NAICS. Top awarding agencies include Department Of Education (ed), Department Of Education, and Department Of Health And Human Services (hhs).

Contact Information

Registration and classification details

Registration

UEI Code

RC9LFKC1MFU3

CAGE Code

4CCP1

Entity Structure

U.S. Government Entity

Established

N/A

Business Classifications

2F

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

Columbus County Schools is a public educational entity focused on delivering K-12 academic services, operational support, and student-centered programs within its local jurisdiction. As a government-funded school district, its core capabilities center on curriculum development, special education ser...

Columbus County Schools is a public educational entity focused on delivering K-12 academic services, operational support, and student-centered programs within its local jurisdiction. As a government-funded school district, its core capabilities center on curriculum development, special education services, instructional technology integration, school safety planning, and facility management for public education environments. The organization applies federal and state educational standards to implement evidence-based pedagogical practices, manage student data systems, and coordinate transportation, nutrition, and student support services. Its technical expertise includes compliance with IDEA and ESSA requirements, implementation of learning management platforms, and coordination of federal grant-funded initiatives for at-risk student populations. No contract award history is available to infer agency relationships beyond its local and state educational oversight structures. As a public school district, it operates under the authority of the North Carolina Department of Public Instruction and receives funding and guidance from the U.S. Department of Education, but no formal federal contracting relationships are documented. The entity does not operate under standard federal NAICS codes for commercial contractors, as its mission is strictly educational service delivery within a public school system rather than government contracting. Its market positioning is confined to local and state-level education administration, not the federal acquisition market. Columbus County Schools is structured as a 2A public educational entity, with no commercial certifications such as 8(a), HUBZone, or WOSB. It maintains a localized geographic presence centered in Whiteville, North Carolina, serving the Columbus County community. Its operations are funded through state appropriations and federal education grants, and it does not engage in commercial contracting or serve external federal agencies as a vendor.

Key Performance Metrics

Awards Count

0

All time

Active

0

Currently performing

Completed

0

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency
Department Of Education (ed)$8.4M38.9%
Department Of Education$5.8M26.9%
Department Of Health And Human Services (hhs)$4.7M22%
Department Of Justice$1.8M8.1%
Department Of Agriculture$660.6K3.1%
Department Of Commerce$177.8K0.8%
Other agencies (1 agencies, <0.5% each)$44.7K0.2%
Awards by NAICS
Export
- Unknown NAICS$21.6M100%
Awards by Agency Over Time
Export
Awards by Place of Performance

Open opportunities in COLUMBUS COUNTY SCHOOLS's top NAICS codes and agencies

NAICS: 334290
New
Federal
THIS IS A NOTICE OF INTENT TO SOLE SOURCE
Solicitation # NOI00271
The U.S. Department of Commerce, through its Office of Acquisition Management on behalf of the National Telecommunications and Information Administration, plans to award a sole-source contract to Outdoor Wireless Network, LLC dba Comsearch for maintenance and support services related to the iQ.link Enterprise software. This contract is intended to support the NTIA Spectrum Analysis and Engineering Division located in Washington, DC, and will initially cover a 12-month base period with the possibility of four additional one-year option periods, extending the potential performance period up to five years. The engagement is critical to ensuring continued operational functionality and technical support for software integral to spectrum management and analysis activities. The solicitation, identified as NOI00271, was posted on August 5, 2026, with a response deadline of August 12, 2026. It falls under NAICS code 334290 for other communications equipment manufacturing and is issued as a special notice with no set-aside provisions, reflecting the decision to proceed without competitive bidding. Erika Crawford from the Department of Commerce is the designated point of contact for inquiries, reachable via ecrawford@doc.gov. The contract will be performed at the NTIA's headquarters at 1401 Constitution Avenue NW, Washington, DC, 20230, and is positioned to sustain mission-critical technical capabilities essential to federal telecommunications oversight.
Department Of Commerce

POSTED

about 12 hours ago

DEADLINE

in 7 days
View Details
NAICS: 513210
New
Federal
Notice of Sole Source: GastroPlus PBPK and PBBM modeling platform subscription
Solicitation # 7571TE26Q00153
The U.S. Food and Drug Administration, through the Department of Health and Human Services, intends to sole-source a firm fixed-price contract to Simulations Plus Inc. for twenty GastroPlus and five DDDPlus software licenses, used for physiologically based pharmacokinetic and physiologically based biopharmaceutics modeling in support of generic drug research. The contract spans a base year from September 1, 2026, to August 31, 2027, with up to three one-year option periods extending through August 31, 2030. Performance will occur at the FDA’s White Oak campus in Silver Spring, Maryland. The acquisition is conducted under RFO 12, allowing for non-competitive procurement of commercial products, and no set-aside applies. Responses are due by August 14, 2026, and any interested party may submit a capability statement to demonstrate their ability to supply the exact software licenses as the original equipment manufacturer or authorized reseller, which the government will review solely to determine whether competitive procurement is warranted. The contract requires the vendor to provide standard individual licenses, with no auto-renewals permitted unless explicitly authorized. Acceptance of deliverables will be conducted by the Contracting Officer’s Representative within 30 working days of delivery, verifying software functionality, compatibility with FDA systems, and compliance with technical requirements. Invoicing must be submitted electronically through the Treasury’s Invoice Processing Platform, and all invoices must include detailed supporting documentation for labor, materials, and costs. The government retains the right to reject nonconforming deliveries and will not pay for services that fail to meet agreed standards. Clauses from the FAR and HHSAR govern payment, representation, whistleblower rights, anti-lobbying, accessibility, and dispute resolution, with federal regulations taking precedence over any vendor terms. The Contracting Officer and Contract Specialist are the primary points of contact, and all vendors must be actively registered in SAM at the time of submission.
Department Of Health And Human Services

POSTED

1 day ago

DEADLINE

in 9 days
View Details
NAICS: 541715
New
Federal
Antioxidant Therapy for Smith-Lemli-Opitz Syndrone
Solicitation # NICHD-08610
The contract pertains to the development and implementation of antioxidant therapy for Smith-Lemli-Opitz Syndrome, a rare genetic disorder characterized by multiple congenital anomalies and metabolic dysfunction. The solicitation, issued under NICHD-08610 by the Department of Health and Human Services through its National Institutes of Health, invites proposals aimed at advancing targeted antioxidant interventions to mitigate the pathological effects of the condition. The opportunity was posted on August 3, 2026, with responses due by August 18, 2026, at 2:00 PM Eastern Time. The work is expected to be performed in Bethesda, Maryland, consistent with the research infrastructure of the NIH campus. All proposals must be submitted through the SAM.gov portal and should address scientific rigor, feasibility, and potential clinical impact. The primary point of contact for inquiries is Niamh Cawley, with Chung Huang as the secondary contact, both reachable via NIH email addresses. The contracting activity falls under the Department of Health and Human Services with no set-aside provisions specified, and no NAICS code is assigned, indicating flexibility in contractor categorization. Interested parties should ensure adherence to deadlines and submission requirements outlined on the official UI link linked in the posting.
Department Of Health And Human Services

POSTED

2 days ago

DEADLINE

in 13 days
View Details
NAICS: 562111
New
Federal
Notice of Intent / Sole Source Solid Waste
Solicitation # 75H71026Q00223
The Navajo Area Indian Health Service, Shiprock Service Unit, intends to award a sole-source, firm-fixed-price contract to Navajo Sanitation for solid waste collection services at the Dzilth-Na-O-Dith-Hle Health Center in Bloomfield, New Mexico, with performance beginning September 1, 2026, and ending August 31, 2027. The procurement is justified under unusual and compelling urgency due to the contractor’s unique, uninterrupted history of providing essential waste management services at the facility, ensuring continuity of operations critical to patient care. The North American Industry Classification System code is 562111, with a small business size standard of $47 million in annual revenue. No competitive solicitation will be issued unless a respondent submits clear and convincing evidence that competition would benefit the government. Responses must be submitted in writing as a capability statement by August 17, 2026, at 10:00 a.m. MST, and must not include proprietary, classified, confidential, or sensitive information. The government is not obligated to respond to or acknowledge submissions, and failure to receive affirmative responses will result in contract award without further notice. All information provided may be used in future solicitations if competition is pursued, and any resulting solicitation will be publicly announced on SAM.gov. The point of contact for inquiries is Ken Parrish, Purchasing Agent, reachable at ken.parrish@ihs.gov.
Department Of Health And Human Services

POSTED

6 days ago

DEADLINE

in 13 days
View Details
NAICS: 333318
Federal
Supply of Dual-Use Benchtop Wirebond-Pull Tester with A-1 Tweezer FeatureThe contract seeks the procurement and delivery of a new, non-refurbished West Bond 70PTE E-Series wirebond-pull tester equipped with an A-1 Tweezer attachment, specifically designed to integrate seamlessly with existing West Bond systems utilized in the assembly of NASA’s Athena mission hardware. The equipment must be factory fresh and fully compatible with current instrumentation to ensure consistent, reliable performance in high-precision bonding validation tasks critical to mission integrity. Delivery is required to meet stringent technical specifications and operational standards aligned with aerospace quality benchmarks. Performance of this contract is designated for Boulder, Colorado, with a response deadline of August 6, 2026, and the solicitation was posted on July 27, 2026. This action falls under the NAICS code 333318, categorizing it as a subcontract for other manufacturing machinery. Although the contracting agency is listed as the Department of Commerce, the end-user context clearly ties the equipment to NASA’s Athena mission, indicating interagency coordination for specialized hardware support. There is no set-aside designation, and the opportunity is open to qualified industrial suppliers capable of meeting the technical, delivery, and compatibility requirements without refurbishment or reconditioning.
Department Of Commerce

POSTED

9 days ago

DEADLINE

in about 17 hours
View Details
NAICS: 334515
Federal
Notice of Intent to Sole Source Wirebond Pull Tester
Solicitation # NB687000-26-02180
The National Institute of Standards and Technology (NIST) plans to award a sole-source firm-fixed-price purchase order to K&R Next Generation Bonding Inc. for a West Bond 70PTE Wire Pull Tester, “E” Series, equipped with an A-1 Tweezer Feature, due to the manufacturer’s discontinuation and the exclusive authorization of this vendor to supply new original equipment. The instrument must meet precise technical specifications including a binocular microscope with 10x eyepieces, twin-array LED illumination, a z-tool range of at least 9/16 inch, z-encoder resolution of 0.002 inch, a test force range of at least 100 grams, force resolution of 0.1 gram or better, force accuracy within ±0.2 gram, ESD protection, and a single-lever dual-counterbalanced micromanipulator with an 8:1 motion-reduction ratio, all while providing a one-year parts warranty. This system is critical for the NIST Quantum Sensors Division’s work on NASA’s Athena X-ray astronomy mission, where precise measurement and controlled removal of wirebonds on flight hardware are required. The decision for sole sourcing is driven by the necessity to maintain compatibility with NIST’s existing fleet of six West Bond wirebonders and diebonders, which share identical optical, mechanical, and electronic components, including the same micromanipulator, stage, control electronics, and tweezer attachments. The division’s 35 current operators are already extensively trained on West Bond systems, and super-users possess proprietary repair knowledge and an established inventory of compatible spare parts. The new tester will be deployed in the commissioning flight lab and is expected to be operated by six to eight current users, eliminating the need for retraining and ensuring seamless integration into existing workflows. West Bond ceased operations at the end of 2025, and K&R Next Generation Bonding Inc. is the sole authorized distributor of new, original West Bond equipment, making it the only viable source for this specific model. The acquisition is governed under FAR Subpart 6.302-1, with a response deadline of August 6, 2026, and an anticipated award on or before August 28, 2026.
Department Of Commerce

POSTED

9 days ago

DEADLINE

in about 17 hours
View Details
NAICS: 541715
SBIR / STTR
NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
Solicitation # PA-27-102
This solicitation supports Small Business Technology Transfer (STTR) grants through the National Institutes of Health to fund research and development projects that advance innovative technologies with potential for commercialization, requiring a formal collaboration between a U.S.-owned small business and a nonprofit research institution. The award is made solely to the small business, regardless of where the principal investigator is employed, and projects must align with the missions of NIH, CDC, or FDA components. Funding is available for Phase I, Phase II, Direct to Phase II, and Fast-Track applications, with Fast-Track allowing combined Phase I and II review to streamline the process. Direct to Phase II is an option for businesses that have already demonstrated technical merit without prior Phase I funding, provided the application is submitted as a new proposal, not a renewal. Only one Phase II award is permitted per Phase I project, and Phase IIB Strategic Breakthrough applications must go through a separate solicitation. Applications must focus on feasibility or R&D that supports public health goals and are subject to restrictions on clinical trials, which are not permitted under this NOFO if exclusively aligned with specific NIH institutes including NIAID, NIAMS, NIDCR, NIDDK, NIMHD, NCATS, and ORIP. The funding opportunity is part of the broader SBIR/STTR mandate, which requires NIH to set aside 0.45% of its extramural budget for STTR, ensuring support for small businesses with fewer than 500 employees. Applicants are encouraged to consult with program staff prior to submission to ensure alignment with funding priorities and to use the Assignment Request Form to suggest an appropriate awarding component, though such identification is not mandatory. The solicitation closes on August 5, 2026, and information on program details, priorities, and frequently asked questions is available through the NIH Seed Fund portal and related government strategies including the Make Our Children Healthy Again initiative.
Department of Health and Human Services

POSTED

2 months ago

DEADLINE

in 8 months
View Details
NAICS: 541715
SBIR / STTR
NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
Solicitation # PA-27-100
This funding opportunity supports U.S. small businesses in advancing early-stage research and development toward commercialization through the SBIR program, administered by the National Institutes of Health, Centers for Disease Control and Prevention, and Food and Drug Administration. Eligible small businesses must be U.S.-owned and operated with fewer than 500 employees and are expected to lead the majority of the technical effort, with the principal investigator primarily employed by the business. The program offers Phase I grants to establish technical feasibility, Phase II grants to advance development toward market readiness, and two special pathways: Direct to Phase II for projects with prior proof of concept but no prior Phase I award, and Fast-Track for combined Phase I and Phase II submissions reviewed concurrently to accelerate progress. All awards are granted to the small business, and commercialization must be pursued using non-SBIR funds after Phase II. The scientific scope must align with the missions of participating NIH, CDC, or FDA components, focusing on health improvement and public health innovation, with applicants encouraged to consult specific institute priorities and the White House’s Make Our Children Healthy Again Strategy. While clinical trials are permitted, they are explicitly excluded if the application aligns solely with certain NIH institutes or all FDA centers, making alignment critical for responsiveness. Applications must be submitted through the designated portal by the deadline, and while applicants are not required to specify an awarding component during submission, consultation with program staff beforehand is strongly advised to ensure proper alignment. The solicitation operates under a complete small business set-aside mandate and is open to new applications only, with no renewals accepted for Direct to Phase II submissions.
Department of Health and Human Services

POSTED

2 months ago

DEADLINE

in 8 months
View Details
NAICS: 541715
SBIR / STTR
SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional)
Solicitation # PAR-27-098
The Commercialization Readiness Pilot (CRP) program, issued under PAR-27-098, provides late-stage research and development funding and technical assistance to U.S. small business concerns that have previously received an NIH SBIR or STTR Phase II award or a Phase IIB Strategic Breakthrough award. This initiative is designed to bridge the gap between Phase II completion and full commercialization by supporting activities that require significant outsourcing, such as regulatory strategy, intellectual property development, manufacturing optimization, pre-clinical product development, and clinical trials—though not all NIH institutes accept clinical trial proposals. The program permits substantial outsourcing to contract research organizations but requires the small business to maintain active oversight and management of all scientific, financial, and administrative aspects of the work, with justified budget allocations reflecting this role. CRP funding cannot cover FDA filing fees or include separate Technical and Business Assistance (TABA) funds. Eligible applicants must be small business concerns under 500 employees meeting SBA size standards, and proposals must align with the mission of participating NIH components. The solicitation explicitly excludes applications that propose clinical trials solely aligned with certain NIH institutes, including NHLBI, NIAID, NIDDK, and others listed, which do not accept such trials under this program. Applications are limited to Type 1 new submissions, and prior Phase II funding is mandatory for eligibility. Applicants are strongly encouraged to consult with NIH program staff before submitting to ensure alignment with the most appropriate funding mechanism, as the Phase IIB Strategic Breakthrough program (PA-27-101) may be better suited for some projects with matching fund requirements. The solicitation is active through August 5, 2026, under a total small business set-aside, and further details are available through the NIH SBIR/STTR portal.
Department of Health and Human Services

POSTED

2 months ago

DEADLINE

in 8 months
View Details